Oncotarget

Research Papers:

Diabetes mellitus and the risk of glioma: a meta-analysis

Luqian Zhao, Zhiping Zheng and Ping Huang _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:4483-4489. https://doi.org/10.18632/oncotarget.6605

Metrics: PDF 1018 views  |   HTML 1749 views  |   ?  


Abstract

Luqian Zhao1, Zhiping Zheng1, Ping Huang1

1Department of Geriatrics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou 510180, Guangzhou, China

Correspondence to:

Ping Huang, e-mail: gzhuangping@126.com

Keywords: diabetes, glioma, association, meta-analysis

Received: September 06, 2015     Accepted: November 28, 2015     Published: December 14, 2015

ABSTRACT

Some studies reported a statistically significant inverse association between diabetes mellitus (DM) and risk of gliomas. However, the result is still controversial. We thus did a meta-analysis and summarized the evidence on the incidence of gliomas that has been studied in its association with DM. Seven case-control studies and 4 cohort studies were selected in this meta-analysis (n = 5898251). DM was significantly associated with decreased risk of gliomas (OR = 0.79; 95% CI 0.67 – 0.93; P = 0.004; I2 = 59%). In the subgroup analysis of race, Caucasians of DM showed decreased risk of gliomas (OR = 0.81; 95% CI 0.69 – 0.94; P = 0.007). In the subgroup analysis of design, a statistically significant protective effect of DM on gliomas was observed in case-control studies (OR = 0.68; 95 % CI, 0.53–0.87; P = 0.002), while no such effect was observed in cohort studies (OR = 0.97; 95 % CI, 0.83–1.13; P = 0.70). In a further stratified analysis by gender, a significant association was found among males with DM (OR = 0.83; 95 % CI, 0.70–0.99; P = 0.04). No significant association was found between females with DM and gliomas (OR = 0.97; 95 % CI, 0.78–1.21; P = 0.81). In summary, this meta-analysis of current evidence suggests that DM is significantly associated with decreased gliomas risk in Caucasian and males.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 6605